Document:

Exhibit 10.1

 

AGREEMENT

 

This Agreement (the
"Agreement"), made as of January 21, 2015, by and among Medbox, Inc., a Nevada corporation (“Medbox”),
P. Vincent Mehdizadeh (“VM”), an individual, PVM International, Inc., a California corporation (“PVM”),
Vincent Chase, Incorporated, a California corporation (“VC”) (VM, PVM and VC are sometimes collectively referred
to herein as the “VM Group”).

 

RECITALS

 

A. Each of the VM Group are shareholders
of Medbox;

 

B. On January 9, 2015, the VM Group filed
a Form 14C (the “Form 14C”) with the Securities Exchange Commission, which included a shareholder written consent
executed by the VM Group (the “Consent”) seeking the appointment of 4 new successor directors specified therein;

 

C. Medbox disputes the legal effectiveness
of the Consent and filed a complaint in the matter entitled, Medbox, Inc. v. P. Vincent Mehdizadeh et. al., LASC No. BC569755 (the
“Complaint”) challenging the Consent;

 

D. Medbox and the VM Group now desire to
resolve their differences in the best interests of Medbox on the terms and conditions set forth in this Agreement.

 

AGREEMENT

 

The parties agree as
follows:

 

1.          Cancellation of the Consent.
Effective on the date of this Agreement, the VM Group hereby cancels and withdraws the Consent, and authorizes Medbox to disclose
to the Securities Exchange Commission and its shareholders on Form 8k, or as otherwise appropriate, that the Consent has been cancelled
and withdrawn. The VM Group will execute and deliver to Medbox any additional documents reasonably requested by Medbox to more
fully give effect to the cancellation of the Consent.

 

2.          Voting Agreement. Concurrently
upon execution of this Agreement, Medbox and the VM Group shall, and Medbox shall cause Ned L. Siegel (“Siegel”),
Mitch Lowe (“Lowe”), Jennifer Love (“Love”) and Guy Marsala (“Marsala”)
(collectively, the “Board”) to execute and deliver to each other a Voting Agreement in the form attached hereto
as Exhibit A providing, for a period commencing on the date of the Voting Agreement and ending 12 months later (the “Voting
Agreement Term”), that (i) each of the parties to the Voting Agreement shall vote in favor of appointment or election
of each of Siegel, Lowe, Love and Marsala as directors of Medbox, whether by written consent or at any annual or special meeting
called for the purpose of removing or electing directors and (ii) the VM Group shall not take any action to remove any of Siegel,
Lowe, Love or Marsala as a director of Medbox, add any other director to the Board or otherwise change the composition or structure
of the Board. After termination of the Voting Agreement Term, such prohibitions and voting requirements shall have no further force
or effect.

 

    	1

    	 

    

 

3.          Dismissal of Complaint.
Within two business days of confirmation that VM Group has completed the actions required in Section 1(a) of this Agreement and
the Voting Agreement has been executed and delivered by the VM Group, Medbox agrees to files a dismissal in the form attached hereto
as Exhibit B.

 

4.          Presentation of Equity
Term Sheet and Appointment of Fifth Director. On or before 5:00 p.m. pacific standard time on January 25, 2015, the VM Group
shall deliver to the Board a written summary of terms from an accredited investor selected by the VM Group providing for the investment
of not less than $1,000,000 in restricted common stock to be issued by Medbox in a private placement, at a modest discount to the
market price of Medbox’s common stock, all on terms as reasonably agreed to by the Board (the “Term Sheet”).
Concurrently with closing of the transactions contemplated by the Term Sheet, Medbox shall cause Siegel, Lowe, Love and Marsala,
in their capacities as directors of Medbox, to vote to appoint a person nominated by VM with industry experience and reasonably
acceptable to the Board as the fifth director of Medbox (“Fifth Director”); provided that if the transaction
contemplated by the Term Sheet does not close, Medbox shall nonetheless cause Siegel, Lowe, Love and Marsala, in their capacities
as directors of Medbox, to appoint a person nominated by VM and reasonably acceptable to the Board as the Fifth Director.

 

5.          Consulting Arrangements
and Contact with Staff. VM confirms that all prior consulting agreements or similar arrangements between him and Medbox or
any of its subsidiaries have been terminated, and that for a period commencing on the date of this Agreement and terminating upon
the end of the Voting Agreement Term, VM will not (i) seek or purport to act on behalf of Medbox or any subsidiary as a consultant,
agent, or otherwise or (ii) except as authorized by the Board or this Agreement, contact or interfere with any Medbox employees,
consultants, directors or shareholders, whether on or off Medbox’s premises and whether in person, by mail, email, Edgar
filings, the internet, press releases, other form of public announcements, or in any other manner. Notwithstanding this Section,
VM Group shall be permitted to have a supervised visit at Medbox’s headquarters where they can gather personal belongings
and make copies of files for the purpose of compiling a financial summary prepared by an accounting firm to disclose to Medbox
and Medbox’s financial consulting firm for assistance with its investigation of the 2012, 2013 and 2014 financial statements.
VM Group will also be allowed to provide to Medbox an operations summary to assist current management in running the business.

 

6.          Board Consultations with VM.
During the Voting Agreement Term, Medbox shall cause one or more of its directors, initially Siegel, to meet and confer in
good faith with VM not less infrequently than semi-monthly (or on a different frequency as mutually agreed by Medbox and VM) to
hear and discuss any matters of interest or concern of VM, as a shareholder of Medbox. These matters shall initially include, but
are not limited to (i) adequacy of Medbox’s staffing, (ii) implementation of new consulting arrangements related to executed
amendments to client consulting agreements previously agreed to by Medbox but not yet tendered to clients as promised, to ensure
client satisfaction and (iii) Medbox’s completion of its evaluation, through Singer Lewak, of its prior period financial
reporting.

 

    	2

    	 

    

 

7.          Confidentiality. Each
of the VM Group agrees and understands that he or it may, during the course of Board consultations as contemplated by Section 6,
receive material non-public or otherwise confidential information regarding the affairs of Medbox, including, but not limited to,
financial information, business and marketing plans, strategies, technical information, intellectual property, financing, leases,
business policies and practices, and other forms of information considered by Medbox to be confidential. Each of the VM Group agrees
to keep such information confidential and will not use or disclose such information, either directly or indirectly, to any third
person without the prior written consent of Medbox; provided, however, that (i) the VM Group shall have no such obligation to the
extent such information is or becomes publicly known other than as a result of any of the VM Group’s breach of this Section,
and (ii) any of the VM Group may, after giving prior written notice to Medbox to the extent practicable under the circumstances,
disclose such information to the extent required by applicable laws or governmental regulations or judicial or regulatory process.
This confidentiality covenant has no temporal, geographical or territorial restriction. While any of the VM Group is in possession
of material non-public information about Medbox, each member of the VM Group shall refrain from participating in any trading activity
of any security of Medbox in any manner that would violate applicable state or federal securities laws.

 

8.          Termination of Agreement.

 

(a) Termination
by VM Group. The VM Group may terminate this Agreement by giving written notice to Medbox of any of the following matters:

 

(i) Medbox shall have failed to
dismiss the Complaint as required by Section 3; or

 

(ii) the Fifth Director shall not
have been timely appointed as provided in Section 4, and such failure remains un-remedied for a period of 5 days following such
notice; or

 

(iii) Medbox fails
or refuses to comply with its obligations under Section 6, and such failure or refusal remains un-remedied for a period of 5 days
following such notice.

 

(b) Termination
by Medbox. Medbox may terminate this Agreement by giving written notice to the VM Group of any of the following matters:

 

(i) the VM Group shall
have failed to timely comply with Section 1; or

 

(ii) the Voting Agreement
shall not have been timely and fully executed and delivered by each of the VM Group as specified in Section 2; or

 

    	3

    	 

    

 

(iii) the VM Group
shall not have timely delivered the Term Sheet as contemplated by Section 4, and such failure remains un-remedied for a period
of 5 days following such notice; or

 

(iv) VM fails or refuses to comply
with his obligations under Section 5.                    

 

(c) Effect of Termination;
Remedies. Upon termination of this Agreement, in addition to all rights and remedies afforded under applicable law, the aggrieved
party shall be relieved of any further obligations under this Agreement and, in the appropriate case, seek injunction relief without
having to prove damages or paying a bond. Notwithstanding the foregoing, the Voting Agreement and the provisions of Sections 5,
7 and 9 shall survive termination of this Agreement.

 

9.          Miscellaneous.

 

9.1           Press Releases. Medbox
shall have the sole right to issue one or more press releases with respect to the execution of this Agreement and the Voting Agreement,
taking into consideration the reasonable comments of the VM Group; provided that in any event (i) Medbox is not obligated to accept
any comments that it believes in good faith would cause the press releases to be materially false or misleading and (ii) this Section
shall not operate to prevent Medbox from timely making any public announcements necessary to comply with applicable securities
laws or the rules of any exchange. Drafts of the proposed press release and related Form 8k with respect to this Agreement are
attached hereto as Exhibit C.

 

9.2          Entire Agreement. This
Agreement, and the agreements executed in connection with this Agreement, set forth the entire agreement and understanding concerning
the subject matter hereof, and supersedes and replaces all prior negotiations and all agreements proposed or otherwise, whether
written or oral, concerning the subject matters hereof. This is an integrated document.

 

9.3           Governing Law. This
Agreement shall be deemed to have been executed and delivered within the State of California, and the rights and obligations of
the parties hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State of California
without regard to principles of conflict of laws.

 

9.4          Construction.
Each party has cooperated in the drafting and preparation of this Agreement and consulted with their respective legal counsel.
Hence, in any construction to be made of this Agreement, the same shall not be construed against any party on the basis that the
party was the drafter.

 

9.5          Waiver. No waiver of
any breach of any term or provisions of this Agreement shall be construed to be, nor shall be, a waiver of any other breach of
this Agreement. No waiver shall be binding unless in writing and signed by the party waiving the breach.

 

    	4

    	 

    

 

9.6          Headings.
The descriptive headings of the several Sections of this Agreement are inserted for convenience only and do not constitute a part
of this Agreement.

 

9.7          Amendment,
Modification and Waiver. This Agreement and its provisions may not be amended, modified or waived except in a writing signed
by the parties.

 

9.8           Counterparts.
This Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall
become effective when one or more counterparts have been signed by each party hereto and delivered to each party hereto.

 

9.9          Further Assurances. All
parties agree to cooperate fully and to execute any and all supplementary documents and to take all additional actions that may
be necessary or appropriate to give full force to the basic terms and intent of this Agreement and which are not inconsistent with
its terms.

 

 

	 	Medbox, Inc.
	 	 	 
	 	By:	/s/ Guy Marsala	 
	 	 	Title: Chief Executive Officer
	 	 	 
	 	 	 
	 	PVM International, Inc.
	 	 	 
	 	By:	/s/ P. Vincent Mehdizadeh	 
	 	 	Title: Chief Executive Officer
	 	 	 
	 	 	 
	 	Vincent Chase, Inc.
	 	 	 
	 	By:	/s/ P. Vincent Mehdizadeh	 
	 	 	Title: Chief Executive Officer
	 	 	 
	 	 	 
	 	/s/ P. Vincent Mehdizadeh	 
	 	P. Vincent Mehdizadeh

 

                    

    	5

    	 

    

EXHIBIT A

 

VOTING AGREEMENT

 

 

    	6

    	 

    

 

EXHIBIT B

 

FORM OF DISMISSAL

 

 

    	7

    	 

    

 

EXHIBIT C

 

DRAFTS OF PRESS RELEASE AND 8K

 

 

 

 

 

 

    	8Exhibit 10.2

 

VOTING AGREEMENT

 

This
Voting Agreement (this “Agreement”) is made and entered into as of January 21, 2015, by and
among Medbox, Inc., a Nevada corporation (the “Company”), P. Vincent Mehdizadeh (“VM”),
an individual, PVM International, Inc., a California corporation (“PVM”), and Vincent Chase, Incorporated,
a California corporation (“VC”) (VM, PVM and VC are sometimes collectively referred to herein as the
“VM Group”) and Ned L. Siegel (“Siegel”), Mitch Lowe (“Lowe”),
Jennifer Love (“Love”) and Guy Marsala (“Marsala”, and collectively with Siegel,
Lowe, and Love, the “SLLM Group”). The VM Group, the SLLM Group and the Company are together sometimes
referred to herein as the “Parties”).

 

Recitals

 

Each member of the
VM Group are the beneficial holders of the Company’s preferred and/or common stock (all such stock referred herein together
as the “VM Stock”) and have voting control over the VM Stock;

 

Each member of the
SLLM Group are beneficial holders of the Company’s common stock (all such stock referred herein together as the “SLLM
Stock”) and have voting control over the SLLM Stock;

 

In connection with
and as a condition to that certain Agreement, dated on the date hereof, amongst certain of the Parties, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree, as follows:

 

		1.	Voting.

 

1.1           VM
Stock and SLLM Stock.

 

(a)           Each of
the VM Group agree to hold all shares of the VM Stock registered in their respective names or beneficially owned by them as of
the date hereof subject to, and to vote VM Stock in accordance with, the provisions of this Agreement.

 

(b)           Each of
the VM Group further agree that any and all other securities of the Company legally or beneficially acquired by each of them after
the date hereof shall constitute and be included as “VM Stock” from and after the time of acquisition under the terms
of this Agreement and shall be voted by the VM Group in accordance with the provisions of this Agreement.

 

(c)           Each of
the SLLM Group agree to hold all shares of the SLLM Stock registered in their respective names or beneficially owned by them as
of the date hereof subject to, and to vote SLLM Stock in accordance with, the provisions of this Agreement.

 

(d)           Each of
the SLLM Group further agree that any and all other securities of the Company legally or beneficially acquired by each of them
after the date hereof shall constitute and be included as “SLLM Stock” from and after the time of acquisition under
the terms of this Agreement and shall be voted by the SLLM Group in accordance with the provisions of this Agreement.

 

    	 

    	 

    

 

1.2           Manner
of Voting. Each of the VM Group and the SLLM Group agree to execute any written consents required to perform the obligations
of this Agreement.

 

1.3           Board
Size. At all annual or special meetings of the stockholders of the Company following the date hereof, each of the VM
Group and the SLLM Group shall vote all of their respective VM Stock and SLLM Stock held by them, respectively (or the holders
thereof shall consent pursuant to an action by written consent of the stockholders of the Company) so as to ensure that the size
of the Company’s Board of Directors (the “Board”) shall be five (5) directors (each a “Director”
and, collectively, the “Directors”).

 

1.4           Election
of Directors. On all matters relating to the election or appointment of the Directors, each of the VM Group and the
SLLM Group agree to vote all shares of VM Stock and SLLM Stock held by them, respectively, (or the holders thereof shall consent
pursuant to an action by written consent of the stockholders of the Company) so as to elect members of the Board as follows:

 

(a)           At each
election of the Directors in which the stockholders of the Company are entitled to elect members of the Board, including at any
annual meeting or special meeting of the stockholders, each member of the VM Group shall vote all of their respective VM Stock
so as to elect or appoint Siegel, Lowe, Love and Marsala as members of the Board, and each member of the SLLM Group shall
vote all of their respective SLLM Stock so as to elect or appoint Siegel, Lowe, Love and Marsala as members of the Board. No member
of the VM Group or the SLLM Group shall, at any time or for any reason, vote, consent, or take any action to remove any of Siegel,
Lowe, Love or Marsala from the Board or vote, consent or take any action to add any other director to the Board or to otherwise
change the composition or structure of the Board, other than as set forth in any written agreement to which the members of the
VM Group and the Company are parties. With regard to any vote taken to fill any vacancy created by the resignation, removal or
death of a Director elected pursuant to this Section 1.4(a), each member of the VM Group and each member of the SLLM Group
shall vote (or the members of such groups shall consent pursuant to an action by written consent of the stockholders of the Company)
for only those nominees selected by the Board to fill the vacancy.

 

1.5           Successors.
The provisions of this Agreement shall be binding upon the successors in interest to any members of the VM Group and the SLLM Group.
The Company shall not permit the transfer more than 10% of the VM Stock (including as a result of a series of related transactions
to the same parties) on its books or issue a new certificate representing any members of the VM Stock unless and until the Person
or Persons to whom such security is to be transferred shall have executed a written agreement, substantially in the form of this
Agreement, pursuant to which such Person or Persons become a party to this Agreement and agree to be bound by all the provisions
hereof as if such Person or Persons were included in the VM Group.

 

1.6           Acknowledgements.
As a result of this Agreement, the Parties concur and acknowledge that the Directors have been appointed by the shareholders
for purposes of any applicable Nevada law or the Company’s bylaws.

 

    	2

    	 

    

 

1.7            Waiver
Of Defenses; Service Of Process. In the event that, for any reason or no reason, whether alleged breach or otherwise,
VM Group violates this Agreement, VM Group waives all defenses and stipulates to the granting of an injunction enforcing the terms
of this Agreement and hereby acknowledges acceptance of service of the complaint against VM Group filed by the Company in the Superior
Court for the State of California in the County of Los Angeles for declaratory relief and violation of Business and Professions
Code Sections 17200 et seq.

 

		2.	REMEDIES; Termination.

 

2.1           Irrevocable
Proxy. Each of VM, PVM and VC (each a “VM Party”) hereby appoints Guy Marsala (or in
the event that Mr. Marsala is unavailable, Mitch Lowe or such other person that may be appointed by the Board), with full power
of substitution, for purposes of any applicable Nevada law or the Medbox bylaws, as the proxy of such VM Party with respect to
the matters set forth in this Agreement, including without limitation, election of persons as members of the Board in accordance
with Section 1.4 hereof, and hereby authorizes him to represent and to vote all of such VM Party’s shares of VMS Stock
in favor of the election of persons as members of the Board determined pursuant to and in accordance with the terms and provisions
of Section 1.4 this Agreement. The proxy granted pursuant to the immediately preceding sentence is given in consideration
of the agreements and covenants of the Parties in connection with the transactions contemplated by this Agreement and, as such,
is coupled with an interest and shall be irrevocable unless and until this Agreement terminates pursuant to Section 2.3
hereof. Each VM Party shall not hereafter, unless and until this Agreement terminates or expires pursuant to Section 2.3
hereof, grant any other proxy or power of attorney with respect to any of the VM Stock, deposit any of the VM Stock into a voting
trust or enter into any agreement (other than this Agreement), arrangement or understanding with any person, directly or indirectly,
to vote, grant any proxy or give instructions with respect to the voting of any of the VM Stock, in each case, with respect to
any of the matters set forth herein. This proxy shall be limited to voting authority for the purpose of electing the parties referenced
herein and shall only be used for that purpose during the term of this Agreement.

 

2.2           Remedies
Cumulative. All remedies, either under this Agreement or by law or otherwise afforded to any Party, shall be cumulative
and not alternative.

 

2.3           Termination.
This Agreement shall continue in full force and effect from the date hereof through the date that is twelve (12) months from the
date hereof and is not terminable for any reason prior to such date; provided that this Agreement shall terminate if all of the
SLLM Group shall have resigned.

 

		3.	Miscellaneous.

 

3.1           Ownership.
Each member of the VM Group represents and warrants to the Company that (a) such VM Party now owns the VM Stock, free and
clear of liens or encumbrances, and has not, prior to or on the date of this Agreement, executed or delivered any proxy or entered
into any other voting agreement or similar arrangement other than one which has expired or terminated prior to the date hereof,
and (b) such VM Party has full power and capacity to execute, deliver and perform this Agreement, which has been duly executed
and delivered by, and evidences the valid and binding obligation of, such VM Party enforceable in accordance with its terms.

 

    	3

    	 

    

 

3.2           Further
Action. Each VM Party or the personal representative thereof and each SLLM Party shall do all things and execute and
deliver all documents as may be necessary or as may be requested by the Company to effect the terms of this Agreement.

 

3.3           Specific
Performance. The Parties hereby declare that it is impossible to measure in money the damages which will accrue to a
party hereto or to their heirs, personal representatives, or assigns by reason of a failure to perform any of the obligations under
this Agreement and agree that the terms of this Agreement shall be specifically enforceable, and the Parties waive any requirement
to have any other Party obtain any bond in connection with the same. If any Party or his or her heirs, personal representatives,
or assigns institutes any action or proceeding to specifically enforce the provisions hereof, any Person against whom such action
or proceeding is brought hereby waives the claim or defense therein that such party or such personal representative has an adequate
remedy at law, and such Person shall not offer in any such action or proceeding the claim or defense that such remedy at law exists.

 

3.4           Governing
Law; Consent to Jurisdiction.  This Agreement shall be governed
by and construed in accordance with the laws of the State of California, without regard to its principles of conflicts of laws. 
Each of the parties hereto irrevocably submits to the exclusive jurisdiction of the courts of the State of California for the purpose
of any suit, action, proceeding or judgment relating to or arising out of this Agreement and the transactions contemplated hereby. 
Service of process in connection with any such suit, action or proceeding may be served on each Party anywhere in the world by
the same methods as are specified for the giving of notices under this Agreement.  Each of the Parties irrevocably consents
to the jurisdiction of any such court in any such suit, action or proceeding and to the laying of venue in such court.  Each
Party irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and
irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient
forum.

 

3.5           Waiver
of Jury Trial. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT
TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

 

3.6           Amendment
or Waiver. This Agreement and its provisions may not be amended, modified or waived except in a writing signed by the
Parties.

 

3.7           Severability.
In the event one or more of the provisions of this Agreement should, for any reason, be held to be invalid, illegal or unenforceable
in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Agreement, and this
Agreement shall be construed as if such invalid, illegal or unenforceable provision had never been contained herein.

 

    	4

    	 

    

 

3.8           Successors.
This Agreement shall inure to the benefit of and be binding upon the Parties and their respective heirs, successors, assigns, administrators,
executors and other legal representatives.

 

3.9           Assignment.
This Agreement is not assignable by any Party.

 

3.10           Waiver.
No waivers of any breach of this Agreement extended by any Party to any other Party shall be construed as a waiver of any rights
or remedies of any other Party or with respect to any subsequent breach.

 

3.11           Notices.
Any notices required in connection with this Agreement shall be in writing and shall be deemed effectively given: (a) upon
personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent during normal
business hours of the recipient; if not, then on the next business day, (c) five (5) days after having been sent by registered
or certified mail, return receipt requested, postage prepaid, or (d) one (1) day after deposit with a nationally recognized
overnight courier, specifying next day delivery, with written verification of receipt. All notices shall be addressed to the holder
appearing on the books of the Company or at such address as such party may designate by ten (10) days advance written notice to
the other parties hereto.

 

3.12           Entire
Agreement. This Agreement, along with the settlement agreement and all other related documents, consents and agreements,
constitute the full and entire understanding and agreement between the Parties with regard to the subjects hereof and thereof and
no party shall be liable or bound to any other in any manner by any representations, warranties, covenants and agreements except
as specifically set forth herein and therein. Notwithstanding the foregoing, this Section 3.12 shall not apply with regard
to any agreements to which any Director is a party with the Company or with any member of the VM Group.

 

3.13           Counterparts.
This Agreement may be executed in one or more counterparts, each of which will be deemed an original, and all of which together
shall constitute one and the same agreement. This Agreement may be executed by facsimile, PDF or TIF signatures.

 

Signatures
on the Following Pages

 

 

 

    	5

    	 

    

 

The parties hereto
have executed this Voting Agreement as of the date first above written.

 

	
        THE COMPANY:

         

        MEDBOX, INC.

         

        By /s/ Guy Marsala                    

        

        Its: Chief Executive Officer

         

        THE VM GROUP:

         
	 
	
        PVM INTERNATIONAL, INC.

         

        By /s/ P. Vincent Mehdizadeh                  

        

        Its: CEO

         
	
         

         

         
	 
	
        VINCENT CHASE, INC.

         

        By /s/ P. Vincent Mehdizadeh 

        

        Its: CEO

         

         

        _/s/ P. Vincent Mehdizadeh_______________

        P. Vincent Mehdizadeh

         

         

        THE SLLM GROUP:

         

         

        /s/ Guy Marsala_____________________

        Guy Marsala

         

         

        /s/ Ned L. Siegel______________________

        Ned L. Siegel

         

         

        /s/ Mitch Lowe________________________

        Mitch Lowe

         

         

        /s/ Jennifer Love _____________________

        Jennifer Love

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]